Stage IIIB Breast Cancer Recruiting Phase 1 / 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs